🇺🇸 FDA
Patent

US 8044185

Conformationally stabilized HIV envelope immunogens and triggering HIV-I envelope to reveal cryptic V3-loop epitopes

granted A61KA61K2039/53A61K2039/54

Quick answer

US patent 8044185 (Conformationally stabilized HIV envelope immunogens and triggering HIV-I envelope to reveal cryptic V3-loop epitopes) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K2039/53, A61K2039/54, A61K2039/545, A61K39/12